Your browser doesn't support javascript.
loading
TGF-beta-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases.
Mohammad, Khalid S; Javelaud, Delphine; Fournier, Pierrick G J; Niewolna, Maria; McKenna, C Ryan; Peng, Xiang H; Duong, Vu; Dunn, Lauren K; Mauviel, Alain; Guise, Theresa A.
Affiliation
  • Mohammad KS; Division of Endocrinology, Department of Medicine, Indiana University PurdueUniversity at Indianapolis, Indianapolis, USA.
Cancer Res ; 71(1): 175-84, 2011 Jan 01.
Article in En | MEDLINE | ID: mdl-21084275
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pteridines / Bone Neoplasms / Receptors, Transforming Growth Factor beta / Protein Kinase Inhibitors / Melanoma Type of study: Guideline / Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Res Year: 2011 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pteridines / Bone Neoplasms / Receptors, Transforming Growth Factor beta / Protein Kinase Inhibitors / Melanoma Type of study: Guideline / Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Res Year: 2011 Document type: Article Affiliation country: United States Country of publication: United States